Formia, Italy

Margherita Valente

This inventor holds 1 USPTO granted patent. Top assignee: Bionucleon S.r.l.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margherita Valente. Retrieved from https://idiyas.com/inventor/margherita-valente

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Margherita Valente: Innovator in Protein Modulation

Introduction

Margherita Valente is a distinguished inventor based in Formia, Italy. She has made significant contributions to the field of biotechnology, particularly in the modulation of protein activity. Her innovative work has led to the development of a patent that addresses important biological processes.

Latest Patents

Margherita Valente holds a patent titled "Inhibition of HRP-3 using modified oligonucleotides." This invention refers to agents designed for modulating the activity of proteins that possess a PWWP domain. The patent showcases her expertise in creating solutions that can impact various biological applications.

Career Highlights

Valente is associated with Bionucleon S.r.l., a company that focuses on advancements in biotechnology. Her role at the company has allowed her to explore and develop innovative solutions in her field. With her dedication and expertise, she has established herself as a key figure in her area of research.

Collaborations

Margherita Valente has collaborated with notable colleagues, including Sara Tosti and Enrico M Bucci. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Margherita Valente's contributions to the field of biotechnology through her patent and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in protein modulation and related applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…